Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
about
Influence of human serum on pharmacodynamic properties of an investigational glycopeptide, LY333328, and comparator agents against Staphylococcus aureus.Antimicrobial Activity and Resistance: Influencing Factors.Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection modelPharmacodynamic modeling of the in vivo interaction between cefotaxime and ofloxacin by using serum ultrafiltrate inhibitory titers.N-terminally modified linear and branched spermine backbone dipeptidomimetics against planktonic and sessile methicillin-resistant Staphylococcus aureus.Effect of serum on the in vitro activities of 11 broad-spectrum antibiotics.Efficacy and safety of cefotaxime in the management of pediatric infections.Effect of ertapenem protein binding on killing of bacteria.Antibacterial activity of resazurin-based compounds against Neisseria gonorrhoeae in vitro and in vivo.Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli.Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum.The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years.Antimicrobial activity of ceftriaxone compared with cefotaxime in the presence of serum albumin.Protein binding and antimicrobial activity of ceftriaxone: comparative assessments by gradient plate technique and time-kill study.Seventy-five years of research on protein binding - do we ever understand?
P2860
Q33697206-F7F962EA-0690-4295-9C84-98FF3AE0B1CEQ33790192-59C4AAE8-48FB-4E72-A431-31E3B4DE3894Q35117243-B9BC8093-3423-40FC-8536-5D087FCD6333Q35136125-0AD59C28-3B13-433A-B9CF-95B41767843EQ35198896-4AF35D10-119E-470B-AAE3-E250EBE6448FQ35282427-DD9A6AE7-EB4B-4395-B8E7-F4DED887E2BEQ36958042-F05F4016-00B5-4E4D-ABC8-12E0AE072DFAQ37488804-982B105F-47F7-44DB-924E-B73E8A622B98Q39566214-BFE41584-E383-46CB-9DE6-473541831CCBQ39814757-5539C74B-E0CE-4212-8303-A80A6DA78E91Q39870885-F7D30858-94F5-4D64-BA80-CEA06B083F8BQ40584325-C3D03E88-AD0B-4924-95D9-78B23E1503A1Q42151894-5DE0B972-ADB7-446F-91BC-BC890FD8F1B7Q45257437-C37754D6-41C3-4AFE-91B4-85593016AFD6Q47381610-7386D616-3C5B-4157-B69C-0A4C48E030D5
P2860
Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Antimicrobial activity of ceft ...... n the presence of human serum.
@ast
Antimicrobial activity of ceft ...... n the presence of human serum.
@en
type
label
Antimicrobial activity of ceft ...... n the presence of human serum.
@ast
Antimicrobial activity of ceft ...... n the presence of human serum.
@en
prefLabel
Antimicrobial activity of ceft ...... n the presence of human serum.
@ast
Antimicrobial activity of ceft ...... n the presence of human serum.
@en
P2860
P356
P1476
Antimicrobial activity of ceft ...... n the presence of human serum.
@en
P2093
P2860
P304
P356
10.1128/AAC.31.5.818
P407
P577
1987-05-01T00:00:00Z